北陆药业(300016.SZ)：获得枸橼酸西地那非口崩片《药品注册证书》

Core Viewpoint - Beilu Pharmaceutical has received approval from the National Medical Products Administration for the registration of sildenafil citrate orally disintegrating tablets, which are designed to treat erectile dysfunction and offer rapid onset and effective results [1] Group 1: Product Details - Sildenafil is a selective inhibitor of phosphodiesterase type 5, used for treating erectile dysfunction, and is known for its rapid action and efficacy [1] - The orally disintegrating tablet form of sildenafil citrate was developed by Pfizer and was approved for import into China in 2019 [1] - This formulation does not require water for consumption, dissolves in the mouth within seconds, and provides a quick onset of action, catering to patients' needs for convenience, rapid effect, and privacy in medication [1]